Orthopaedic Biomechanics group, Regenerative Engineering & Materials cluster, Dept. of Biomedical Engineering and the Institute for Complex Molecular Systems, Eindhoven University of Technology, The Netherlands.
Acta Biomater. 2021 Jul 1;128:236-249. doi: 10.1016/j.actbio.2021.04.008. Epub 2021 Apr 21.
Regenerative therapies for articular cartilage are currently clinically available. However, they are associated with several drawbacks that require resolution. Optimizing chondrocyte expansion and their assembly, can reduce the time and costs of these therapies and more importantly increase their clinical success. In this study, cartilage organoids were quickly mass produced from bovine chondrocytes with a new suspension expansion protocol. This new approach led to massive cell proliferation, high viability and the self-assembly of organoids. These organoids were composed of collagen type II, type VI, glycosaminoglycans, with Sox9 positive cells, embedded in a pericellular and interterritorial matrix similarly to hyaline cartilage. With the goal of producing large scale tissues, we then encapsulated these organoids into alginate hydrogels with different viscoelastic properties. Elastic hydrogels constrained the growth and fusion of the organoids inhibiting the formation of a tissue. In contrast, viscoelastic hydrogels allowed the growth and fusion of the organoids into a homogenous tissue that was rich in collagen type II and glycosaminoglycans. The encapsulation of organoids to produce in vitro neocartilage also proved to be superior to the conventional method of encapsulating 2D expanded chondrocytes. This study describes a multimodal approach that involves chondrocyte expansion, organoid formation and their assembly into neohyaline-cartilage which proved to be superior to the current standard approaches used in cartilage tissue engineering. STATEMENT OF SIGNIFICANCE: In this manuscript, we describe a new and simple methodology to quickly mass produce self-assembling cartilage organoids. Due to their matrix content and structure similarities with native cartilage, these organoids on their own have the potential to revolutionize cartilage research and the manner in which we study signaling pathways, disease progression, tissue engineering, drug development, etc. Furthermore, these organoids and their fast mass production were combined with a key relatively ignored hydrogel characteristic, viscoelasticity, to demonstrate their fusion into a neo-tissue. This has the potential to open the door for large scale cartilage regeneration such as for entire joint surfaces.
目前已有用于关节软骨的再生疗法在临床上应用。然而,这些疗法存在多种缺陷,需要加以解决。优化软骨细胞的扩增及其组装,可以减少这些疗法的时间和成本,更重要的是提高其临床成功率。在这项研究中,我们使用一种新的悬浮扩增方案,从牛软骨细胞中快速大量生成软骨体。这种新方法导致了大量的细胞增殖、高存活率和软骨体的自组装。这些软骨体由Ⅱ型和Ⅵ型胶原、糖胺聚糖组成,有 Sox9 阳性细胞,嵌入到类似于透明软骨的细胞外基质和细胞间基质中。为了生产大规模组织,我们将这些软骨体包封到具有不同粘弹性的藻酸盐水凝胶中。弹性水凝胶限制了软骨体的生长和融合,从而抑制了组织的形成。相比之下,粘弹性水凝胶允许软骨体生长和融合成富含Ⅱ型胶原和糖胺聚糖的同质组织。将软骨体包封以产生体外新软骨也被证明优于传统的包封二维扩增软骨细胞的方法。本研究描述了一种多模式方法,涉及软骨细胞扩增、软骨体形成及其组装成新的透明软骨,这被证明优于软骨组织工程中目前使用的标准方法。研究意义:在本手稿中,我们描述了一种快速大量生产自组装软骨体的新的简单方法。由于其基质成分和结构与天然软骨相似,这些软骨体本身有可能彻底改变软骨研究以及我们研究信号通路、疾病进展、组织工程、药物开发等的方式。此外,这些软骨体及其快速大量生产与一个相对被忽视的关键水凝胶特性(粘弹性)相结合,以证明它们融合成新组织。这有可能为大规模软骨再生(如整个关节表面)开辟大门。